Physician Assistant in Stateline, NV Accepting Medicare
3 Physician Assistant nurses found. Showing 1 - 3
 Ms. Jeanne C Horton, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 276 Kingsbury Grade, Suite 101, Stateline, NV 89449 Phone: 775-588-5000 Fax: 775-588-5001 |
Ashley Nicole Williamson, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 256 Tramway Drive, Stateline, NV 89449 Phone: 408-649-9078 |
 Kyle Machynia, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 276 Kingsbury Grade, Suite 101, Stateline, NV 89449 Phone: 775-588-5000 Fax: 775-588-5001 |
News Archive
Reconstructive surgery using custom-made spinal rods may improve outcomes
Custom fit is the key when it comes to spinal implant rods, which an estimated 38,000 people need each year. This need is especially great for people who have a spinal deformity such as scoliosis, which causes the spine to twist and turn into complex and sometimes dangerous positions. In 2011, an estimated 1.6 million people received treatment for scoliosis according to the Bone and Joint Initiative, a consortium of professional medical societies.
Allos to complete merger with AMAG Pharmaceuticals
Allos Therapeutics, Inc. today announced that it continues to work with AMAG Pharmaceuticals, Inc. towards the completion of their merger, pending stockholder approval and satisfaction of the other conditions to closing described in Allos' definitive proxy statement filed with the SEC on September 15, 2011.
Study aims to investigate antimicrobial resistance of uropathogenic E. coli from elderly patients
Urinary Tract Infection is a common cause of morbidity and mortality in older adults. Escherichia coli is one of the bacterial agents with higher prevalence in community-acquired and health care associated urinary infections in elderly patients.
FDA issues interim safety and risk assessment of Melamine and Melamine-related compounds in food
The U.S. Food and Drug Administration (FDA) has issued the results of its interim safety and risk assessment of melamine and melamine-related compounds in food, including infant formula.
Data from four Phase 2 trials of AMG 145 to be presented at AHA Scientific Sessions 2012
Amgen will present data from four Phase 2 trials of AMG 145, an investigational fully human monoclonal antibody directed against PCSK9, a protein that reduces the liver's ability to remove low density lipoprotein cholesterol, or "bad" cholesterol from the blood, at the upcoming American Heart Association Scientific Sessions 2012.
› Verified 3 days ago